StemCell Therapy

As GlaxoSmithKline prepares Voltaren Arthritis Pain for a sizable prescription-to-OTC switch next month, a new pre-order promotion will donate to the Arthritis Foundation.

Through May 12, the official Voltaren OTC availabilityday in the U.S., customers can order the NSAID osteoarthritis gelto getfirst-day at-home delivery through GSK Consumer Healthcare e-commerce partners. Profits from the sales will go to the Arthritis Foundation.

The awareness-buildingand pre-order effort is underway as behind the scenes, GSK is fine-tuning Voltarens prescription to OTC priority launch marketing push that will include TV, print, radio, in-store, digital and social advertising.

FiercePharma Presents the Virtual eRegulatory Operations Summit

Join industry experts and learn how to build and manage cohesive, compliant, and timely electronic submissions through innovative technologies and seamless clinical documentation processes.

RELATED:GSK looks for another OTC allergy crossover hit in newly launched Flonase Sensimist

GSK has the benefit of lessons learned from the Flonase allergy nasal spray prescription to OTC launch several years ago, said Jissan Cherian, Voltaren marketing director.Many of the same executives are still at GSK Consumer Healthcarechief marketing officer Amardeep Kahlon, in fact, oversaw the Flonase switch in 2015and while e-commerce has changed since then, other strategies have carried over.

In-store promotions, for instance, will follow the Flonase lead and use custom display units to educate consumers at point of sale, Cherian said. The multi-channel and extensive ad campaign looks to beanother nod to the Flonase model.

The campaign will seek to expand the Voltaren audience based on GSK research that found osteoarthritis begins for some people in their 30s. Without revealing specific creative, Cherian said a range of ages and life stages will be featured and that the brand will look to establish itself as a movement brand. The Voltaren website will be a first-ever for arthritis patients, created to be user friendly for their specific hand movement issues, he said.

RELATED:GlaxoSmithKline's spinoff plan is hereand it may not be limited to consumer health

As we saw with Flonase, once it becomes over the counter, we have an opportunity to engage a very large patient population and thats exactly what we want to do with Voltaren, Cherian said.

The Arthritis Foundation partnership began with GSK approaching the group to share research and validate its thinking for Voltaren. Thatevolved into the current awareness promotion, with the pre-order and e-commerce idea becoming even more relevant as the COVID-19 pandemic and stay-at-home orders developed.

The rest is here:
GSK partners with Arthritis Foundation as it preps Voltaren for OTC switch - FiercePharma

This entry was posted on May 3, 2020 at 3:47 pm and is filed under Arthritis. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |